39.60
+0.60
+(1.54%)
As of 4:32:19 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
742.00
11,580.00
35,380.00
29,390.00
42,983.00
Operating Expense
653,939.00
498,765.00
293,659.00
217,398.00
153,680.00
Operating Income
-653,197.00
-487,185.00
-258,279.00
-188,008.00
-110,697.00
Net Non Operating Interest Income Expense
84,332.00
47,179.00
9,154.00
917.00
2,167.00
Other Income Expense
--
115.00
--
--
--
Pretax Income
-566,718.00
-439,891.00
-249,125.00
-187,091.00
-108,530.00
Tax Provision
343.00
-3,524.00
-420.00
--
-371.00
Net Income Common Stockholders
-567,061.00
-436,367.00
-248,705.00
-187,091.00
-110,378.00
Diluted NI Available to Com Stockholders
-567,061.00
-436,367.00
-248,705.00
-187,091.00
-110,378.00
Basic EPS
-3.66
-3.86
-3.08
-2.57
-2.01
Diluted EPS
-3.66
-3.86
-3.08
-2.57
-2.01
Basic Average Shares
159,555.24
113,149.87
80,626.53
72,806.08
54,874.12
Diluted Average Shares
159,555.24
113,149.87
80,626.53
72,806.08
54,874.12
Total Operating Income as Reported
-653,197.00
-487,185.00
-258,279.00
-188,008.00
-110,697.00
Total Expenses
653,939.00
498,765.00
293,659.00
217,398.00
153,680.00
Net Income from Continuing & Discontinued Operation
-567,061.00
-436,367.00
-248,705.00
-187,091.00
-108,159.00
Normalized Income
-570,649.97
-436,367.00
-248,705.00
-187,091.00
-108,159.00
Interest Income
84,635.00
47,482.00
9,154.00
929.00
2,238.00
Interest Expense
--
303.00
--
12.00
71.00
Net Interest Income
84,332.00
47,179.00
9,154.00
917.00
2,167.00
EBIT
-605,600.00
-439,588.00
-249,125.00
-187,079.00
-108,459.00
EBITDA
-594,305.00
-430,279.00
-239,469.00
-179,747.00
-101,914.00
Reconciled Depreciation
11,295.00
9,309.00
9,656.00
7,332.00
6,545.00
Net Income from Continuing Operation Net Minority Interest
-567,061.00
-436,367.00
-248,705.00
-187,091.00
-108,159.00
Total Unusual Items Excluding Goodwill
4,543.00
--
--
--
--
Total Unusual Items
4,543.00
--
--
--
--
Normalized EBITDA
-598,848.00
-430,279.00
-239,469.00
-179,747.00
-101,914.00
Tax Rate for Calcs
0.00
0.00
0.00
--
0.00
Tax Effect of Unusual Items
954.03
--
--
--
--
12/31/2020 - 2/17/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2GH.MU Merus NV
39.60
+1.54%
4DN.MU Denali Therapeutics Inc.
22.29
0.00%
ISI.DU Ionis Pharmaceuticals Inc
30.43
-3.49%
IONS.MX Ionis Pharmaceuticals, Inc.
673.00
0.00%
ISI.BE Ionis Pharmaceuticals Inc
31.39
-3.21%
ISI.MU Ionis Pharmaceuticals Inc
31.90
-2.92%
2GH.BE Merus NV
40.00
0.00%
ISI.SG Ionis Pharmaceuticals Inc
31.51
+1.09%
AM6.DU Amicus Therapeutics Inc
9.30
+2.76%
ISI.F Ionis Pharmaceuticals, Inc.
31.52
-3.46%